Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T14:58:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, with the study history otherwise unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T15:26:17.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A notice about NIH website updates explains that federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.4%
    Check dated 2026-10-24T18:13:10.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T18:10:51.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the study record information remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T19:07:40.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.6.6 to v3.7.0, indicating a newer build of the study record history UI.
    Difference
    0.1%
    Check dated 2026-09-19T19:09:00.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.